日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reply to Mitsuboshi, "Enhancing result reliability by addressing potential confounding factors"

回复 Mitsuboshi,“通过解决潜在的混杂因素来提高结果可靠性”

Ishigo, Tomoyuki; Matsumoto, Kazuaki; Yoshida, Hiroaki; Tanaka, Hiroaki; Ibe, Yuta; Fujii, Satoshi; Fukudo, Masahide; Fujihara, Hisato; Yamaguchi, Fumihiro; Ebihara, Fumiya; Maruyama, Takumi; Hamada, Yukihiro; Samura, Masaru; Nagumo, Fumio; Komatsu, Toshiaki; Tomizawa, Atsushi; Takuma, Akitoshi; Chiba, Hiroaki; Nishi, Yoshifumi; Enoki, Yuki; Taguchi, Kazuaki; Suzuki, Ayako

Oral β-lactam combinations are effective in vitro against Mycobacterium avium, regardless of clarithromycin susceptibility

口服β-内酰胺类抗生素组合在体外对鸟分枝杆菌有效,无论其对克拉霉素是否敏感。

Yoshikawa, Maiko; Nishimura, Tomoyasu; Misawa, Kana; Shimamura, Rina; Suzuki, Kenta; Kashimura, Shoko; Igarashi, Yuki; Enoki, Yuki; Taguchi, Kazuaki; Hasegawa, Naoki; Namkoong, Ho; Matsumoto, Kazuaki

Simulated achievement rate of β-lactams/nacubactam treatment in humans using instantaneous MIC-based PK/PD analysis

利用瞬时MIC值PK/PD分析模拟β-内酰胺类/那库巴坦类药物在人体中的治疗达标率

Igarashi, Yuki; Taguchi, Kazuaki; Enoki, Yuki; Chuang, Victor Tuan Giam; Matsumoto, Kazuaki

Establishment and validation of downsized hollow-fibre infection model and pharmacokinetics/pharmacodynamics analysis of VAN on Enterococcus faecium

建立和验证小型化中空纤维感染模型,并分析万古霉素对粪肠球菌的药代动力学/药效学

Hayashi, Yukitaka; Takahashi, Mishu; Sasaki, Moe; Suzuki, Kenta; Mizukami, Yuki; Liu, Xiaoxi; Enoki, Yuki; Taguchi, Kazuaki; Yamaguchi, Tetsuo; Tateda, Kazuhiro; Matsumoto, Kazuaki

CKD-Induced Oxidative Twitch Muscle Atrophy Is Mediated by TGF- β

CKD诱导的氧化性肌肉萎缩是由TGF-β介导的

Homma, Kyoka; Enoki, Yuki; Taguchi, Kazuaki; Matsumoto, Kazuaki

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

伊沙康唑治疗侵袭性真菌感染的疗效和安全性:随机对照试验的系统评价和荟萃分析

Kawasaki, Ayano; Shintani, Ryuya; Takao, Risa; Nakazawa, Yuka; Mihara, Takayuki; Ikegami, Shintaro; Shimada, Sora; Matsumoto, Yuri; Okamoto, Yuko; Igarashi, Yuki; Enoki, Yuki; Taguchi, Kazuaki; Matsumoto, Kazuaki

Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced age

建立和验证万古霉素在老年患者中的群体药代动力学模型

Takada, Keisuke; Samura, Masaru; Igarashi, Yuki; Suzuki, Ayako; Ishigo, Tomoyuki; Fujii, Satoshi; Ibe, Yuta; Yoshida, Hiroaki; Tanaka, Hiroaki; Ebihara, Fumiya; Maruyama, Takumi; Hamada, Yukihiro; Komatsu, Toshiaki; Tomizawa, Atsushi; Takuma, Akitoshi; Chiba, Hiroaki; Yagi, Yusuke; Nishi, Yoshifumi; Enoki, Yuki; Taguchi, Kazuaki; Tanikawa, Koji; Kunishima, Hiroyuki; Matsumoto, Kazuaki

Shortening the interval between the first and the second dose of vancomycin facilitates rapid achievement of the target AUC without increasing the risk of acute kidney injury, provided the AUC on the second day is appropriately controlled: a multicenter retrospective study

缩短万古霉素首剂和次剂之间的给药间隔有助于快速达到目标AUC,且不会增加急性肾损伤的风险,前提是第二天AUC得到适当控制:一项多中心回顾性研究

Ishigo, Tomoyuki; Suzuki, Ayako; Ibe, Yuta; Fujii, Satoshi; Fukudo, Masahide; Yoshida, Hiroaki; Tanaka, Hiroaki; Fujihara, Hisato; Yamaguchi, Fumihiro; Ebihara, Fumiya; Maruyama, Takumi; Hamada, Yukihiro; Yagi, Yusuke; Samura, Masaru; Nagumo, Fumio; Komatsu, Toshiaki; Tomizawa, Atsushi; Takuma, Akitoshi; Chiba, Hiroaki; Nishi, Yoshifumi; Enoki, Yuki; Taguchi, Kazuaki; Matsumoto, Kazuaki

Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study

万古霉素浓度-时间曲线下面积与危重患者肾毒性的关系:一项多中心回顾性研究

Ishigo, Tomoyuki; Matsumoto, Kazuaki; Yoshida, Hiroaki; Tanaka, Hiroaki; Ibe, Yuta; Fujii, Satoshi; Fukudo, Masahide; Fujihara, Hisato; Yamaguchi, Fumihiro; Ebihara, Fumiya; Maruyama, Takumi; Hamada, Yukihiro; Samura, Masaru; Nagumoi, Fumio; Komatsu, Toshiaki; Tomizawa, Atsushi; Takuma, Akitoshi; Chiba, Hiroaki; Nishi, Yoshifumi; Enoki, Yuki; Taguchi, Kazuaki; Suzuki, Ayako

The relationship between controlled ovarian stimulation protocol, meiotic spindle visibility, position of the meiotic spindle relative to the polar body in the human oocyte, and clinical outcomes following ICSI

控制性卵巢刺激方案、减数分裂纺锤体可见性、减数分裂纺锤体相对于人卵母细胞极体的位置以及卵胞浆内单精子注射(ICSI)后临床结局之间的关系。

Inoue, Taketo; Matsuo, Yuki; Taguchi, Sayumi; Tsujimoto, Yoshiko; Uemura, Mikiko; Yamashita, Yoshiki